Is Congress harming pharmaceutical research by limiting enforcement of improvement patents?
Robert L. Stoll
Advertisement
Articles by Robert L. Stoll
Advertisement
Latest Updated Articles
- Attacks on Pharmaceutical Improvement Patents
Published: August 21st 2019 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
TrumpRx and the Dawn of Direct-to-Consumer Commercialization
2
Could DTC Programs Help Simplify the Drug-Pricing System?
3
Lilly Enters Definitive Agreement Acquiring Aderum Biotechnologies
4
AI Becomes Pharma’s New Operating System: Q&A with causaLens’ CEO and Co-Founder Darko Matovski
5
